WASHINGTON, Oct 1 (Reuters) - U.S. regulators said on Monday they were reviewing whether certain osteoporosis drugs, including those made by Merck Inc and Novartis AG, may be linked to a dangerously fast heartbeat.
WASHINGTON, Oct 1 (Reuters) - U.S. regulators said on Monday they were reviewing whether certain osteoporosis drugs, including those made by Merck Inc and Novartis AG, may be linked to a dangerously fast heartbeat.
